The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue ...

Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the ...

Validated next-generation sequencing soon will become necessary in ensuring the safety and efficacy of cell and gene ...

Biomarker testing has become “increasingly critical” in the care of non-small cell lung cancer.A new investigation into testing rates proved “reassuring” to Kenneth L. Kehl, MD, MPH, assistant ...

Life sciences and diagnostics company Revvity has had a busy couple of years, playing a major role in the next-generation sequencing-based screening of newborns to better enable healthcare ...